0.12Open0.15Pre Close6 Volume71 Open Interest75.00Strike Price29.00Turnover53.39%IV4.01%PremiumNov 29, 2024Expiry Date0.00Intrinsic Value100Multiplier1DDays to Expiry0.03Extrinsic Value100Contract SizeAmericanOptions Type-0.0403Delta0.0475Gamma2603.33Leverage Ratio-0.1068Theta-0.0001Rho-104.92Eff Leverage0.0030Vega
DexCom Stock Discussion
Revenue came in at $994.2 million, topping the forecast of $990.71 million and showing growth from last year's $975 million.
The company announced that Teri Lawver, EVP and Chief Commercial Officer, will retire by year-end, with CEO Kevin Sayer temporarily leading the commercial team.
DexCom reaffirmed its 2024 sales outl...
Great products sells itself, ask novo disk and how they sell ozempic
No comment yet